| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JHEP.2003.10.023 |
| P698 | PubMed publication ID | 14739102 |
| P2093 | author name string | Young Bae Kim | |
| Ja Kyung Kim | |||
| Young Nyun Park | |||
| Haeryoung Kim | |||
| Kwang-Hyup Han | |||
| Chanil Park | |||
| Jinsub Choi | |||
| P433 | issue | 2 | |
| P921 | main subject | liver carcinoma | Q18557387 |
| phenotype | Q104053 | ||
| P304 | page(s) | 298-304 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype | |
| P478 | volume | 40 |
| Q53229266 | A case of primary biliary cirrhosis that complicated with combined hepatocellular and cholangiocellular carcinoma. |
| Q48718249 | A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition. |
| Q33327426 | Altered regulation of Prox1-gene-expression in liver tumors |
| Q36100711 | Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma |
| Q34431278 | Bmi1 is required for hepatic progenitor cell expansion and liver tumor development |
| Q34141556 | C-KIT-positive undifferentiated tumor of the liver: A case report |
| Q34975197 | Cancer stem cells in primary liver cancers: pathological concepts and imaging findings. |
| Q24650846 | Characterization of CD133+ parenchymal cells in the liver: histology and culture |
| Q41337317 | Cholangiolocellular carcinoma with satellite nodules showing intermediate differentiation |
| Q37675494 | Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. |
| Q35158765 | Clinicopathologic study on combined hepatocellular carcinoma and cholangiocarcinoma: with emphasis on the intermediate cell morphology |
| Q51147978 | Clinicopathological significance of 'subtypes with stem-cell feature' in combined hepatocellular-cholangiocarcinoma. |
| Q37856825 | Combined hepatocellular and cholangiocarcinoma associated with hepatolithiasis: report of a case. |
| Q35936570 | Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography |
| Q60928177 | Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions |
| Q26749446 | Combined hepatocellular cholangiocarcinoma: Controversies to be addressed |
| Q64098715 | Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends |
| Q36732055 | Combined hepatocholangiocarcinoma: case-series and review of literature |
| Q64106600 | Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation |
| Q87677698 | Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesis |
| Q36728718 | Ductular reaction is helpful in defining early stromal invasion, small hepatocellular carcinomas, and dysplastic nodules. |
| Q38969232 | Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice |
| Q33574625 | Establishment of a human hepatoma multidrug resistant cell line in vitro |
| Q36672168 | Evidence regarding a stem cell origin of hepatocellular carcinoma |
| Q34115360 | Expression of deleted in malignant brain tumours 1 (DMBT1) relates to the proliferation and malignant transformation of hepatic progenitor cells in hepatitis B virus-related liver diseases |
| Q47423452 | Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study |
| Q36638176 | Hepatic progenitor cells in human liver tumor development |
| Q38155513 | Hepatic progenitor cells: their role and functional significance in the new classification of primary liver cancers. |
| Q51665999 | Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. |
| Q36032796 | Hepatocellular progenitor cell tumor of the gallbladder: a case report and review of the literature |
| Q42114895 | Hepatocellular tumors: immunohistochemical analyses for classification and prognostication |
| Q36835856 | High expression of cancer stem cell markers in cholangiolocellular carcinoma |
| Q53325736 | High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis. |
| Q34136980 | Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. |
| Q53467129 | Histopathological classification of hepatocellular carcinoma. |
| Q90293297 | IGF2 mRNA Binding Protein 2 Transgenic Mice Are More Prone to Develop a Ductular Reaction and to Progress Toward Cirrhosis |
| Q43509730 | Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma |
| Q54620206 | Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma. |
| Q37269530 | Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiation |
| Q37358938 | Liver stem cells and hepatocellular carcinoma |
| Q50156868 | Mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: a possible stem cell tumor? |
| Q36466007 | Modeling drug- and chemical-induced hepatotoxicity with systems biology approaches. |
| Q34394789 | Modulation of mitochondrial permeability transition pore affects multidrug resistance in human hepatocellular carcinoma cells |
| Q41979111 | Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity. |
| Q48000860 | Mutational landscape of combined hepatocellular carcinoma and cholangiocarcinoma, and its clinicopathological significance |
| Q21284740 | Nonalcoholic fatty liver disease and hepatocellular carcinoma |
| Q36920568 | Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey |
| Q36528920 | Origin of hepatocellular carcinoma: role of stem cells |
| Q34127764 | Outcome of Combined Hepatocellular and Cholangiocarcinoma of the Liver |
| Q36672172 | Pancreatic stem cells: differentiation options |
| Q37783344 | Pathology of combined hepatocellular‐cholangiocarcinoma |
| Q53325916 | Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis. |
| Q43010111 | Poorly differentiated hepatocellular carcinoma with unusual tubular structures. |
| Q38408142 | Post-resection Prognosis of Combined Hepatocellular Carcinoma-Cholangiocarcinoma According to the 2010 WHO Classification. |
| Q38420005 | Postresection Outcomes of Combined Hepatocellular Carcinoma-Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. |
| Q37552925 | Primary liver tumors: origin and target therapy |
| Q36233866 | Prognosis of hepatocellular carcinoma expressing cytokeratin 19: comparison with other liver cancers |
| Q92875468 | Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications |
| Q34259112 | Role of liver stem cells in hepatocarcinogenesis |
| Q53382084 | Spalt-like transcription factor 4 immunopositivity is associated with epithelial cell adhesion molecule expression in combined hepatocellular carcinoma and cholangiocarcinoma. |
| Q47420668 | Stochastic phenotype switching leads to intratumor heterogeneity in human liver cancer. |
| Q89769430 | Surgical Treatment of Hepatocholangiocarcinoma: A Systematic Review |
| Q27022499 | Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature |
| Q35097226 | TGF-β signaling alters the pattern of liver tumorigenesis induced by Pten inactivation |
| Q53541451 | Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma. |
| Q36774499 | The CD79α (HM47/A9) antibody is effective in distinguishing between primary hepatocellular carcinoma and primary intrahepatic cholangiocarcinoma |
| Q33929406 | The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. |
| Q53150174 | The expression of arginase-1, keratin (K) 8 and K18 in combined hepatocellular-cholangiocarcinoma, subtypes with stem-cell features, intermediate-cell type. |
| Q36672523 | The identification of stem cells in human liver diseases and hepatocellular carcinoma |
| Q40152544 | Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. |
| Q54643443 | Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers. |
| Q58761168 | Very Rare Liver Neoplasm: Lymphoepithelioma-Like () Hepatocellular Carcinoma |
| Q54985330 | Whole-exome sequencing reveals the origin and evolution of hepato-cholangiocarcinoma. |
| Q53668933 | [Which stem cells for adult liver?]. |
| Q48513742 | cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. |
Search more.